Gene cloning,expression and immune adjuvant properties of the recombinant fusion peptide Tβ4-BP5

wang chen,guo xiangling,li xiaokang,li deyuan,chen puyan
DOI: https://doi.org/10.16303/j.cnki.1005-4545.2015.09.15
2015-01-01
Abstract:Thymosinβ4(Tβ4)and bursopentin(BP5)are both associated with immune regulation.To investigate whether the recommbinant fusion peptide Tβ4-BP5 is also related to the immune response,gene of Tβ4-BP5 was synthesized according to the preferential codons of E.coli,fused with prokaryotic expression vector pET-32α,and then transferred into E.coli BL21 to induce its expression.To evaluate the immune adjuvant properties of Tβ4-BP5,chicken were immunized with Tβ4-BP5 combined with inactivated H9N2 AIV vaccine.The titers of HI antibody,antigen-specific antibodies,AIV-neutralizing antibodies and levels of Th1-type cytokines(IFN-γ)and Th2-type cytokines(IL-4)were assessed subsequently,meanwhile,its immune protective effects were estimated by virus challenge experiment.The results showed that Tβ4-BP5 was expressed in E.coli,and it could enhance titers of HI antibody and antigen-specific IgG antibodies,promote the secretion of AIV-neutralizing antibodies and Th1-and Th2-type cytokines in post-immuned SPF chicken,which suggested that the fusion peptide Tβ4-BP5 could enhance the humoral and cellular immune responses.Detection results of virus in lungs of challenged SPF chicken showed that Tβ4-BP5 could contribute to the removal of lungs virus(H9N2AIV(A/chicken/Jiangsu/NJ07/05))in chicken,which demonstrated that Tβ4-BP5 had immune adjuvant potential.This study lays a foundation for the further development of the new vaccine adjuvants.
What problem does this paper attempt to address?